Bryan Love to Drug Approval
This is a "connection" page, showing publications Bryan Love has written about Drug Approval.
Connection Strength
0.183
-
Regulatory and clinical considerations for biosimilar oncology drugs. Lancet Oncol. 2014 Dec; 15(13):e594-e605.
Score: 0.119
-
Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2016 Feb; 36(2):203-17.
Score: 0.032
-
The changing landscape of adverse drug events associated with chronic hepatitis C virus therapy. Expert Opin Drug Saf. 2015; 14(11):1649-52.
Score: 0.031